Of utmost importance, future research should concentrate on devising effective therapeutic strategies aimed at inhibiting LCN2 activity, with the goal of enhancing the treatment and outcomes for patients afflicted with breast cancer brain metastasis. This evidence concerns the gene LCN2 and breast carcinoma.